Whitehawk Therapeutics (WHWK) Short-term Investments (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 7 years of Short-term Investments data on file, last reported at $88.3 million in Q1 2026.

• On a quarterly basis, Short-term Investments rose 2426.57% year-over-year to $88.3 million in Q1 2026; TTM through Mar 2026 was $88.3 million, a 2426.57% increase from a year earlier, with the FY2025 full-year figure at $108.1 million, up 482.37% from the prior year.
• Short-term Investments for Q1 2026 stood at $88.3 million, down from $108.1 million in the prior quarter.
• Over the last five years, Short-term Investments for WHWK reached as high as $133.5 million in Q4 2022 and fell as low as $3.5 million in Q1 2025.
• Historically, Short-term Investments has averaged $62.8 million across 5 years, with a median of $48.2 million in 2022.
• Across the five-year window, Short-term Investments plunged 89.87% in 2025 and soared 2426.57% in 2026, its largest moves.
• Year by year, Short-term Investments stood at $133.5 million in 2022, then tumbled by 65.59% to $46.0 million in 2023, then plunged by 59.6% to $18.6 million in 2024, then soared by 482.37% to $108.1 million in 2025, then decreased by 18.38% to $88.3 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $88.3 million in Q1 2026, $108.1 million in Q4 2025, and $124.7 million in Q3 2025.